Georgios Mikellides

Georgios Mikellides is a Clinical Associate Professor of Psychiatry at the University of Nicosia Medical School and a UK-trained Consultant Psychiatrist. He holds the MRCPsych and is a Fellow of the Royal College of Psychiatrists since 2022. His academic roles include Honorary Clinical Lecturer at Queen Mary University of London and Course Lead for the Mental Health module in the Graduate Entry Medicine Programme at the University of Nicosia. He has served as an Honorary Research Associate at King’s College London’s IoPPN and as a Special Scientist at the University of Cyprus.

Dr. Mikellides’ education includes a PhD from Maastricht University (focusing on rTMS and ketamine treatments), an MD from Charles University, and certifications in rTMS from Harvard and Maastricht. His research emphasizes rTMS applications in medicine, ketamine’s clinical use, and treatment-resistant depression. Clinically, he integrates biological and psychological approaches, including Psychodynamic Psychotherapy, CBT, and CAT.

His research trends highlight neuromodulation innovations, comparative efficacy studies of rTMS and ketamine, and rare neurological presentations. Awards include Fellowship of the Royal College of Psychiatrists and CCT certification. He has advised on medical education and contributed to diabetes psychiatry services improving glycaemic control and psychological outcomes.

Key collaborations include work with clinical teams in Cyprus and the UK, focusing on translational research and clinical integration of neuromodulation therapies. His work bridges academic research, clinical practice, and medical education, emphasizing evidence-based innovation in psychiatry.